
                                SEQUENCE LISTING

<110> LABYRX IMMUNOLOGIC THERAPEUTICS (USA) LIMITED 

<120> LABYRINTHIN-BASED PEPTIDES FOR CANCER IMMUNOTHERAPIES AND
      USES THEREOF

<130> 18572-20001.40

<140> Not Yet Assigned
<141> Concurrently Herewith

<150> US 62/779,377
<151> 2018-12-13

<160> 32

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 255
<212> PRT
<213> Homo sapiens

<400> 1
Met Val Ile Ala Leu Leu Gly Val Trp Thr Ser Val Ala Val Val Trp
 1               5                  10                  15      
Phe Asp Leu Val Asp Tyr Glu Glu Val Leu Gly Lys Leu Gly Ile Tyr
            20                  25                  30          
Asp Ala Asp Gly Asp Gly Asp Phe Asp Val Asp Asp Ala Lys Val Leu
        35                  40                  45              
Leu Gly Leu Lys Glu Arg Ser Thr Ser Glu Pro Ala Val Pro Pro Glu
    50                  55                  60                  
Glu Ala Glu Pro His Thr Glu Pro Glu Glu Gln Val Pro Val Glu Ala
65                  70                  75                  80  
Glu Pro Gln Asn Ile Glu Asp Glu Ala Lys Glu Gln Ile Gln Ser Leu
                85                  90                  95      
Leu His Glu Met Val His Ala Glu His Val Glu Gly Glu Asp Leu Gln
            100                 105                 110         
Gln Glu Asp Gly Pro Thr Gly Glu Pro Gln Gln Glu Asp Asp Glu Phe
        115                 120                 125             
Leu Met Ala Thr Asp Val Asp Asp Arg Phe Glu Thr Leu Glu Pro Glu
    130                 135                 140                 
Val Ser His Glu Glu Thr Glu His Ser Tyr His Val Glu Glu Thr Val
145                 150                 155                 160 
Ser Gln Asp Cys Asn Gln Asp Met Glu Glu Met Met Ser Glu Gln Glu
                165                 170                 175     
Asn Pro Asp Ser Ser Glu Pro Val Val Glu Asp Glu Arg Leu His His
            180                 185                 190         
Asp Thr Asp Asp Val Thr Tyr Gln Val Tyr Glu Glu Gln Ala Val Tyr
        195                 200                 205             
Glu Pro Leu Glu Asn Glu Gly Ile Glu Ile Thr Glu Val Thr Ala Pro
    210                 215                 220                 
Pro Glu Asp Asn Pro Val Glu Asp Ser Gln Val Ile Val Glu Glu Val
225                 230                 235                 240 
Ser Ile Phe Pro Val Glu Glu Gln Gln Glu Val Pro Pro Asp Thr
                245                 250                 255 


<210> 2
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 2
Glu Pro Ala
 1          


<210> 3
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 3
Val Pro Pro Glu
 1              


<210> 4
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 4
Glu Pro His
 1          


<210> 5
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 5
Glu Pro Glu
 1          


<210> 6
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 6
Val Pro Val
 1          


<210> 7
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 7
Glu Pro Gln
 1          


<210> 8
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 8
Gly Pro Thr
 1          


<210> 9
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 9
Asn Pro Asp
 1          


<210> 10
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 10
Glu Pro Val
 1          


<210> 11
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 11
Glu Pro Leu
 1          


<210> 12
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 12
Ala Pro Pro Glu
 1              


<210> 13
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 13
Asn Pro Val
 1          


<210> 14
<211> 3
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 14
Phe Pro Val
 1          


<210> 15
<211> 4
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 15
Val Pro Pro Asp
 1              


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 16
Glu Pro Ala Val Pro Pro Glu
 1               5          


<210> 17
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 17
Val Pro Pro Glu Glu Ala Glu Pro His
 1               5                  


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 18
Glu Pro His Thr Glu Pro Glu
 1               5          


<210> 19
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 19
Glu Pro Glu Glu Gln Val Pro Val
 1               5              


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 20
Val Pro Val Glu Ala Glu Pro Gln
 1               5              


<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 21
Gly Pro Thr Gly Glu Pro Gln
 1               5          


<210> 22
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 22
Asn Pro Asp Ser Ser Glu Pro Val
 1               5              


<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 23
Ala Pro Pro Glu Asp Asn Pro Val
 1               5              


<210> 24
<211> 12
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 24
Phe Pro Val Glu Glu Gln Gln Glu Val Pro Pro Asp
 1               5                  10          


<210> 25
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 25
Asp Gly Pro Thr Gly Glu Pro Gln Gln Glu
 1               5                  10  


<210> 26
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 26
Glu Gln Glu Asn Pro Asp Ser Ser Glu Pro Val
 1               5                  10      


<210> 27
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 27
Ala Pro Pro Glu Asp Asn Pro Val Glu Asp
 1               5                  10  


<210> 28
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 28
Glu Glu Gln Gln Glu Val Pro Pro Asp
 1               5                  


<210> 29
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 29
Gly Glu Asp Leu Gln Gln Glu Asp Gly Pro Thr Gly Glu Pro Gln Gln
 1               5                  10                  15      
Glu Asp Asp Glu Phe Leu
            20          


<210> 30
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 30
Asp Met Glu Glu Met Met Ser Glu Gln Glu Asn Pro Asp Ser Ser Glu
 1               5                  10                  15      
Pro Val Val Glu Asp Glu
            20          


<210> 31
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 31
Asn Glu Gly Ile Glu Ile Thr Glu Val Thr Ala Pro Pro Glu Asp Asn
 1               5                  10                  15      
Pro Val Glu Asp Ser Gln
            20          


<210> 32
<211> 23
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic Construct

<400> 32
Asp Ser Gln Val Ile Val Glu Glu Val Ser Ile Phe Pro Val Glu Glu
 1               5                  10                  15      
Gln Gln Glu Val Pro Pro Asp
            20              

